In HIV/HCV co-infected patients T regulatory and myeloid-derived suppressor cells persist after successful treatment with directly acting antivirals

被引：14
|
作者：
Tumino, Nicola [1 ]
Casetti, Rita [1 ]
Fabbri, Gabriele [2 ]
Cimini, Eleonora [1 ]
Romanelli, Antonella [1 ]
Turchi, Federica [1 ]
Forini, Olindo [1 ]
Bordoni, Veronica [1 ]
Antinori, Andrea [2 ]
Ammassari, Adriana [2 ]
Sacchi, Alessandra [1 ]
Agrati, Chiara [1 ]
机构：
[1] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Dept Epidemiol Preclin Res & Adv Diagnost, Rome, Italy
[2] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Clin Dept, Rome, Italy
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 67卷 / 02期
关键词：
CHRONIC HEPATITIS-C; ANTIRETROVIRAL THERAPY; CLINICAL-SIGNIFICANCE; COINFECTED PATIENTS;
D O I：
10.1016/j.jhep.2017.03.036
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：422 / 424
页数：4
相关论文
共 50 条
  • [31] Depressive symptoms after interferon treatment for HIV/HCV co-infected out-patients
    Blanch, Jordi
    Laguno, M.
    Pons, A.
    Mallolas, J.
    NERVENARZT, 2007, 78 : 110 - 111
  • [32] HIV/HCV co-infected patients experience HCV viral rebound after the second day of IFN treatment
    Mika, BP
    McCarthy, ME
    Layden, TJ
    Wiley, TE
    HEPATOLOGY, 1999, 30 (04) : 195A - 195A
  • [33] Lower proportion of sustained virologic response and higher residual HCV viremia at the end of direct-acting antivirals treatment in HIV/HCV co-infected as compared with HCV mono-infected patients: meaning and correlates
    Mastrorosa, I.
    Comandini, U. V.
    Ammassari, A.
    Fabbri, G.
    Garbuglia, A. R.
    Capobianchi, M. R.
    D'Offizi, G.
    Lionetti, R.
    Vergori, A.
    Giannetti, A.
    Antinori, A.
    Zaccarelli, M.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S510 - S510
  • [34] Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders
    Uemura, Haruka
    Tsukada, Kunihisa
    Mizushima, Daisuke
    Aoki, Takahiro
    Watanabe, Koji
    Kinai, Ei
    Teruya, Katsuji
    Gatanaga, Hiroyuki
    Kikuchi, Yoshimi
    Sugiyama, Masaya
    Mizokami, Masashi
    Oka, Shinichi
    PLOS ONE, 2017, 12 (10):
  • [35] First Real Life Evidence of New Direct-acting Antivirals (DAA) in Co-infected HIV HCV Patients: Better than Ever
    Menard, Amelie
    Colson, Philippe
    Catherine, Dhiver
    Isabelle, Ravaux
    Christelle, Tomei
    Meddeb, Line
    Ben Ali, Souad
    Solas, Caroline
    Stein, Andreas
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (07)
  • [36] Altered frequency of myeloid-derived suppressor cells (MDSC) and regulatory T cells (Treg) in peripheral blood of patients with psoriasis
    Wegner, J.
    Krebs, F. K.
    Tuettenberg, A.
    von Stebut, E.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (03) : E58 - E58
  • [37] Safety analysis of raltegravir/truvada regimen in HIV/HCV co-infected patients without switchback after HCV treatment
    Ehret, Robert
    Walter, Hauke
    Ingiliz, Patrick
    Baumgarten, Axel
    Obermeier, Martin
    Krznaric, Ivanka
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 100 - 101
  • [38] Proportion of Regulatory T Lymphocytes and Myeloid-derived Suppressor Cells in Peripheral Blood of Patients With Uterine Cervical Cancer
    Kim, Yong-Man
    Lee, Shin Wha
    Lee, Ha-Young
    Kim, Dae-Yeon
    Kim, Jong-Hyeok
    Kim, Young-Tak
    Nam, Joo-Hyun
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 965 - 965
  • [39] ACTIVATION OF INNATE IMMUNITY CELLS MAY PREDICT EARLY HCV TREATMENT OUTCOME IN HIV/HCV CO-INFECTED PATIENTS
    Sacchi, A.
    Lalle, E.
    Vlassi, C.
    Vitali, A.
    D'Offizi, G.
    Martini, F.
    Abbate, I.
    Rozera, G.
    Capobianchi, M. R.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S323 - S323
  • [40] Evaluation of Immune Function, Renal Function, and Glycemic Control in HIV/HCV Co-Infected Patients Successfully Treated for Chronic HCV with Direct-Acting Antivirals.
    Patel, Sonali K.
    Patel, Manish
    Kriengkauykiat, Jane
    Miller, Lesley
    HEPATOLOGY, 2018, 68 : 602A - 602A
12345